182 related articles for article (PubMed ID: 14605324)
21. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
22. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
[TBL] [Abstract][Full Text] [Related]
23. Lowering C-reactive protein with statins after an ischemic stroke avoids mortality and readmissions. A prospective cohort study.
Arévalo-Lorido JC; Carretero-Gómez J; Fernández-Recio JM; Alvarez-Oliva A; Gutiérrez-Montaño C; Najarro-Díez F; Martín-Sánchez MJ
Ann Med; 2015 May; 47(3):226-32. PubMed ID: 25895539
[TBL] [Abstract][Full Text] [Related]
24. The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition.
Harrap SB; Tzourio C; Cambien F; Poirier O; Raoux S; Chalmers J; Chapman N; Colman S; Leguennec S; MacMahon S; Neal B; Ohkubo T; Woodward M;
Hypertension; 2003 Sep; 42(3):297-303. PubMed ID: 12925557
[TBL] [Abstract][Full Text] [Related]
25. Association of circulating high-sensitivity C-reactive protein with late recurrence after ischemic stroke.
Zhang YB; Yin Z; Han X; Wang Q; Zhang Z; Geng J
Neuroreport; 2017 Jul; 28(10):598-603. PubMed ID: 28542069
[TBL] [Abstract][Full Text] [Related]
26. Plasma C-Reactive Protein and Clinical Outcomes after Acute Ischemic Stroke: A Prospective Observational Study.
Matsuo R; Ago T; Hata J; Wakisaka Y; Kuroda J; Kuwashiro T; Kitazono T; Kamouchi M;
PLoS One; 2016; 11(6):e0156790. PubMed ID: 27258004
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin 2 type 2 receptor activity and ischemic stroke severity.
Ovbiagele B; Kidwell CS; Starkman S; Selco SL; Rajajee V; Razinia T; Saver JL
Neurology; 2005 Sep; 65(6):851-4. PubMed ID: 16186522
[TBL] [Abstract][Full Text] [Related]
28. Effect of prestroke use of angiotensin-converting enzyme inhibitors alone versus combination with antiplatelets and statin on ischemic stroke outcome.
Hassan Y; Al-Jabi SW; Aziz NA; Looi I; Zyoud SH
Clin Neuropharmacol; 2011; 34(6):234-40. PubMed ID: 21996648
[TBL] [Abstract][Full Text] [Related]
29. Combination of High-Sensitivity C-Reactive Protein and Homocysteine Predicts the Post-Stroke Depression in Patients with Ischemic Stroke.
Cheng LS; Tu WJ; Shen Y; Zhang LJ; Ji K
Mol Neurobiol; 2018 Apr; 55(4):2952-2958. PubMed ID: 28456936
[TBL] [Abstract][Full Text] [Related]
30. A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure.
Savarese G; Costanzo P; Cleland JG; Vassallo E; Ruggiero D; Rosano G; Perrone-Filardi P
J Am Coll Cardiol; 2013 Jan; 61(2):131-42. PubMed ID: 23219304
[TBL] [Abstract][Full Text] [Related]
31. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up.
Eveson DJ; Robinson TG; Potter JF
Am J Hypertens; 2007 Mar; 20(3):270-7. PubMed ID: 17324738
[TBL] [Abstract][Full Text] [Related]
32. C-reactive protein and outcome after ischemic stroke.
Muir KW; Weir CJ; Alwan W; Squire IB; Lees KR
Stroke; 1999 May; 30(5):981-5. PubMed ID: 10229731
[TBL] [Abstract][Full Text] [Related]
33. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype.
Ladenvall C; Jood K; Blomstrand C; Nilsson S; Jern C; Ladenvall P
Stroke; 2006 Aug; 37(8):2018-23. PubMed ID: 16809555
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein predicts further ischemic events in transient ischemic attack patients.
Purroy F; Montaner J; Molina CA; Delgado P; Arenillas JF; Chacon P; Quintana M; Alvarez-Sabin J
Acta Neurol Scand; 2007 Jan; 115(1):60-6. PubMed ID: 17156267
[TBL] [Abstract][Full Text] [Related]
35. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
36. Association of hyponatremia in acute stroke stage with three-year mortality in patients with first-ever ischemic stroke.
Huang WY; Weng WC; Peng TI; Chien YY; Wu CL; Lee M; Hung CC; Chen KH
Cerebrovasc Dis; 2012; 34(1):55-62. PubMed ID: 22759703
[TBL] [Abstract][Full Text] [Related]
37. Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
Fransen M; Anderson C; Chalmers J; Chapman N; Davis S; MacMahon S; Neal B; Sega R; Terent A; Tzourio C; Woodward M;
Stroke; 2003 Oct; 34(10):2333-8. PubMed ID: 12958329
[TBL] [Abstract][Full Text] [Related]
38. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke.
Efstathiou SP; Tsioulos DI; Tsiakou AG; Gratsias YE; Pefanis AV; Mountokalakis TD
Stroke; 2005 Sep; 36(9):1915-9. PubMed ID: 16109902
[TBL] [Abstract][Full Text] [Related]
39. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis.
Lip GY; Patel JV; Hughes E; Hart RG
Stroke; 2007 Apr; 38(4):1229-37. PubMed ID: 17332453
[TBL] [Abstract][Full Text] [Related]
40. A significant temporal and quantitative relationship exists between high-density lipoprotein levels and acute ischemic stroke presentation.
Russman AN; Schultz LR; Zaman IF; Rehman MF; Silver B; Mitsias P; Nerenz DR
J Neurol Sci; 2009 Apr; 279(1-2):53-6. PubMed ID: 19195663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
